What is Precigen's EBITDA?

Precigen (PGEN) reported EBITDA of -$4.9M in Q1 2026.

How has Precigen's EBITDA changed year-over-year?

Precigen's EBITDA increased by 77.7% year-over-year, from -$21.97M to -$4.9M.

What is the long-term trend for Precigen's EBITDA?

Over 3 years (2021 to 2024), Precigen's EBITDA has grown at a 12.3% compound annual growth rate (CAGR), from -$92.2M to -$130.5M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Precigen PGEN EBITDA

EBITDA at other companies

Viridian Therapeutics, Inc.VRDN

-$116.05M-23.8%

Agios PharmaceuticalsAGIO

-$108.66M-3.1%

Apogee Therapeutics, Inc.APGE

-$82.36M-31.0%

Bristol-Myers SquibbBMY

——

Regeneron PharmaceuticalsREGN

——

Gilead SciencesGILD

——

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

−$6.0Mebit+

$1.1MDepreciation Depletion & Amortization

=-$4.9M

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's EBITDA?: Precigen (PGEN) reported EBITDA of -$4.9M in Q1 2026.
How has Precigen's EBITDA changed year-over-year?: Precigen's EBITDA increased by 77.7% year-over-year, from -$21.97M to -$4.9M.
What is the long-term trend for Precigen's EBITDA?: Over 3 years (2021 to 2024), Precigen's EBITDA has grown at a 12.3% compound annual growth rate (CAGR), from -$92.2M to -$130.5M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.